Translational implications of somatic genomics in acute myeloid leukaemia. (Q38235586)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25079101%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

title

Translational implications of somatic genomics in acute myeloid leukaemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25079101%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

1 reference

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25079101%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Ross L Levine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25079101%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

publication date

1 August 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25079101%20AND%20SRC:MED&resulttype=core&format=json

Lancet Oncology Commission

11 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25079101%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25079101%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25079101%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

page(s)

e382-94

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25079101%20AND%20SRC:MED&resulttype=core&format=json

Molecular prognostic markers for adult acute myeloid leukemia with normal cytogenetics

11 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

Prognostic relevance of integrated genetic profiling in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

Retinoic acid and arsenic trioxide for acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

Patients with t(8;21)(q22;q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administered

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

Targeting epigenetic programs in MLL-rearranged leukemias

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

MLL-rearranged leukemia is dependent on aberrant H3K79 methylation by DOT1L.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

Disclosure of Candidate Genes in Acute Myeloid Leukemia With Complex Karyotypes Using Microarray-Based Molecular Characterization

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

TP53 gene mutation is frequent in patients with acute myeloid leukemia and complex karyotype, and is associated with very poor prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

Monosomal karyotype in acute myeloid leukemia: a better indicator of poor prognosis than a complex karyotype

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

A retrospective study of 69 patients with t(6;9)(p23;q34) AML emphasizes the need for a prospective, multicenter initiative for rare ‘poor prognosis’ myeloid malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

Acquired copy number alterations in adult acute myeloid leukemia genomes

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

Use of whole-genome sequencing to diagnose a cryptic fusion oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

Molecular genetics of adult acute myeloid leukemia: prognostic and therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

IDH1 and IDH2 mutations are frequent genetic alterations in acute myeloid leukemia and confer adverse prognosis in cytogenetically normal acute myeloid leukemia with NPM1 mutation without FLT3 internal tandem duplication

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

Insertion of FLT3 internal tandem duplication in the tyrosine kinase domain-1 is associated with resistance to chemotherapy and inferior outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

Prognostic impact of FLT3-ITD load in NPM1 mutated acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

Allo-SCT for high-risk AML-CR1 in the molecular era: impact of FLT3/ITD outweighs the conventional markers.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

FLT3 tyrosine kinase domain mutations are biologically distinct from and have a significantly more favorable prognosis than FLT3 internal tandem duplications in patients with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

FLT3 D835/I836 mutations are associated with poor disease-free survival and a distinct gene-expression signature among younger adults with de novo cytogenetically normal acute myeloid leukemia lacking FLT3 internal tandem duplications

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

Biologic and clinical significance of the FLT3 transcript level in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

Acute myeloid leukaemia blast cells with a tyrosine kinase domain mutation of FLT3 are less sensitive to lestaurtinib than those with a FLT3 internal tandem duplication

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

Phase IB study of the FLT3 kinase inhibitor midostaurin with chemotherapy in younger newly diagnosed adult patients with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

Double CEBPA mutations, but not single CEBPA mutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely associated with a favorable outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

Hyperactive Ras in developmental disorders and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

Screening for MLL tandem duplication in 387 unselected patients with AML identify a prognostically unfavorable subset of AML

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

Long-term disease-free survivors with cytogenetically normal acute myeloid leukemia and MLL partial tandem duplication: a Cancer and Leukemia Group B study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

RUNX1 mutations in acute myeloid leukemia: results from a comprehensive genetic and clinical analysis from the AML study group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a Cancer and Leukemia Group B Study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

Efficacy and safety of imatinib in adult patients with c-kit-positive acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

AML1-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutations

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

Clonal heterogeneity as detected by metaphase karyotyping is an indicator of poor prognosis in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

Karyotype instability between diagnosis and relapse in 117 patients with acute myeloid leukemia: implications for resistance against therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

Recurring mutations found by sequencing an acute myeloid leukemia genome

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

DNMT3A Mutations in Acute Myeloid Leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

Frequency, onset and clinical impact of somatic DNMT3A mutations in therapy-related and secondary acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

Dnmt3a is essential for hematopoietic stem cell differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

Prognostic impact of IDH2 mutations in cytogenetically normal acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

Mutation in TET2 in myeloid cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic category

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

ASXL1 mutations promote myeloid transformation through loss of PRC2-mediated gene repression

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

PHF6 mutations in adult acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

Mutational inactivation of STAG2 causes aneuploidy in human cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

The origin and evolution of mutations in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

SF3B1 and other novel cancer genes in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

Frequent pathway mutations of splicing machinery in myelodysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

SRSF2 mutations in primary myelofibrosis: significant clustering with IDH mutations and independent association with inferior overall and leukemia-free survival

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

Defects in spliceosomal machinery: a new pathway of leukaemogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

ERG expression is an independent prognostic factor and allows refined risk stratification in cytogenetically normal acute myeloid leukemia: a comprehensive analysis of ERG, MN1, and BAALC transcript levels using oligonucleotide microarrays

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk molecular features: a Cancer and Leukemia Group B Study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

Prognostically useful gene-expression profiles in acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

Expression of CD2 in acute promyelocytic leukemia correlates with short form of PML-RARalpha transcripts and poorer prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

Distinctive patterns of microRNA expression associated with karyotype in acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

H3K79 methylation profiles define murine and human MLL-AF4 leukemias

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

Relation between CXCR-4 expression, Flt3 mutations, and unfavorable prognosis of adult acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

Targeting of CD44 eradicates human acute myeloid leukemic stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

Monitoring of minimal residual disease in NPM1-mutated acute myeloid leukemia: a study from the German-Austrian acute myeloid leukemia study group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

Minimal residual disease levels assessed by NPM1 mutation-specific RQ-PCR provide important prognostic information in AML.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

Real-time quantitative polymerase chain reaction detection of minimal residual disease by standardized WT1 assay to enhance risk stratification in acute myeloid leukemia: a European LeukemiaNet study.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

NPM1 mutation is a stable marker for minimal residual disease monitoring in acute myeloid leukaemia patients with increased sensitivity compared to WT1 expression.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

Prognostic relevance of treatment response measured by flow cytometric residual disease detection in older patients with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

The beginning of the end of the beginning in cancer genomics

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

Population-specific genetic variants important in susceptibility to cytarabine arabinoside cytotoxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

Prognostic significance of the null genotype of glutathione S-transferase-T1 in patients with acute myeloid leukemia: increased early death after chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

Recognizing familial myeloid leukemia in adults

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970008-7

7 January 2021

10.1016/S1470-2045(14)70008-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25079101%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25079101%20AND%20SRC:MED&resulttype=core&format=json